Evidence map›Paper›PMID 31517546›Full record

ArticleIntegrative cancer therapies

Protective Effect of Traditional Chinese Medicine Formula RP on Lung Microenvironment in Pre-Metastasis Stage of Breast Cancer.

Yiyi Ye, Lixia Pei, Chunyu Wu, Sheng Liu

Open access · goldAbstract read
In one paragraph

Article in Integrative cancer therapies. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
1.0field-weighted citation impact, top 29% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 22 citations in OpenAlex.

  1. Antiviral and Immune Enhancement Effect ofMolecules (Basel, Switzerland) · 2025
    Review
  2. Article
  3. Review
  4. Article
  5. Fibroblasts: invigorated targets in pre-metastatic niche formation.International journal of biological sciences · 2024
    Review
  6. Review
  7. Inhibitory Effect ofEvidence-based complementary and alternative medicine : eCAM · 2023
    Article
  8. Pharmaceutical biology · 2021
    Article
  9. Article
  10. Review
  11. Alkannin Inhibits the Development of Ovarian Cancer by Affecting miR-4461.Evidence-based complementary and alternative medicine : eCAM · 2021
    Article
  12. Review
  13. Article
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Yiyi YeLongHua Hospital, Shanghai University of Traditional Chinese Medicine, Shanghai, China.
Lixia PeiLongHua Hospital, Shanghai University of Traditional Chinese Medicine, Shanghai, China.
Chunyu WuLongHua Hospital, Shanghai University of Traditional Chinese Medicine, Shanghai, China.
Sheng LiuLongHua Hospital, Shanghai University of Traditional Chinese Medicine, Shanghai, China.ORCID 0000-0003-0670-5389
Shanghai University of Traditional Chinese Medicine · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

AnimalsBreast NeoplasmsCell Line, TumorChemokine CXCL2Chemokine CXCL5Disease Models, AnimalDrugs, Chinese HerbalFemaleInflammationInterleukin-1betaInterleukin-6LungLung NeoplasmsMedicine, Chinese TraditionalMiceMice, Inbred BALB CChemokine CXCL2Chemokine CXCL5Drugs, Chinese HerbalInterleukin-1betaInterleukin-6Protective Agentsbreast cancerlung metastasispre-metastatic microenvironmenttraditional Chinese medicine

Identifiers

PMID31517546
PMCPMC7242796
OpenAlexW2973059793

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.